Türkiye's Update: Key Changes In Named Patient Program

Pharmaceuticals that are not authorized in Türkiye or authorized but not available on the market shall be procured from abroad as per a special authorization and on a case by case basis (Named Patient Program-NPP). This supply can be conducted by public institutions approved by the Ministry of
Health that are defined as Foreign Pharmaceutical Suppliers (Suppliers) and currently constitute the
Social Security Institution and the Turkish Pharmacists Association. The Suppliers can procure the product
from a foreign entity defined as the Pharmaceutical Drug Source, which shall have a Representative
based in Türkiye.

On April 17, 2024, the Guidelines on Supply of Pharmaceuticals from Abroad (Guidelines), which contains the guiding provisions regarding the implementation of the Regulation on Supply of Pharmaceuticals from Abroad (Regulation) was amended.